OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
Dhiraj Mannar, James W. Saville, Xing Zhu, et al.
Science (2022) Vol. 375, Iss. 6582, pp. 760-764
Open Access | Times Cited: 613

Showing 1-25 of 613 citing articles:

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Rigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 700-705
Open Access | Times Cited: 625

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 687-692
Open Access | Times Cited: 596

SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 479

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
Ana Cecilia Ulloa, Sarah A. Buchan, Nick Daneman, et al.
JAMA (2022) Vol. 327, Iss. 13, pp. 1286-1286
Open Access | Times Cited: 282

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 262

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203

Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4780-4791
Open Access | Times Cited: 192

Molecular basis of receptor binding and antibody neutralization of Omicron
Hong Qin, Wenyu Han, Jiawei Li, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 546-552
Open Access | Times Cited: 189

Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2011-2024
Open Access | Times Cited: 183

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181

Structural diversity of the SARS-CoV-2 Omicron spike
S. Gobeil, Rory Henderson, Victoria Stalls, et al.
Molecular Cell (2022) Vol. 82, Iss. 11, pp. 2050-2068.e6
Open Access | Times Cited: 179

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 178

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
Tongqing Zhou, Lingshu Wang, John Misasi, et al.
Science (2022) Vol. 376, Iss. 6591
Open Access | Times Cited: 152

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148

Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
Linjie Li, Hanyi Liao, Yumin Meng, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2952-2960.e10
Open Access | Times Cited: 143

Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 142

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
Cheng Li, Wuqiang Zhan, Zhenlin Yang, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1389-1401.e18
Open Access | Times Cited: 138

Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Alief Moulana, Thomas Dupic, Angela M. Phillips, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 123

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
Zhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 121

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116

Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function
Darren P. Martin, Spyros Lytras, Alexander G. Lucaci, et al.
Molecular Biology and Evolution (2022) Vol. 39, Iss. 4
Open Access | Times Cited: 110

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 108

Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96

Page 1 - Next Page

Scroll to top